In vitro evaluation of the DP-4M PennCentury™ insufflator

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 88, Issue 1, 2014, Pages 153-159

  Hoppentocht, M ^a   Hoste, C ^b   Hagedoorn, P ^a   Frijlink, H W ^a   De Boer, A H ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Dispersion efficiency; Insufflation; Intratracheal; Mice; Particle size distribution; Pulmonary delivery

Indexed keywords

AEROSOL; POWDER;

AEROSOL; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRY POWDER INHALER; EQUIPMENT DESIGN; EVALUATION STUDY; INHALATIONAL DRUG ADMINISTRATION; LASER; MOUSE; PARTICLE SIZE; POWDER; PRESSURE; RESPIRATORY SYSTEM; TRACHEA;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; DRUG DELIVERY SYSTEMS; DRY POWDER INHALERS; EQUIPMENT DESIGN; LASERS; MICE; PARTICLE SIZE; POWDERS; PRESSURE; RESPIRATORY SYSTEM; TRACHEA;

EID: 84934274409     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2014.06.014     Document Type: Article

References (35)

1. D. Traini, and P.M. Young Delivery of antibiotics to the respiratory tract: an update Exp. Opin. Drug Deliver. 6 2009 897 905
2. J.S. Patton, and P.R. Byron Inhaling medicines: delivering drugs to the body through the lungs Nat. Rev. Drug Discov. 6 2007 67 74
3. P. Muttil, C. Wang, and A. Hickey Inhaled drug delivery for tuberculosis therapy Pharm. Res. 26 2009 2401 2416
4. V. Saluja, J.P. Amorij, J.C. Kapteyn, A.H. de Boer, H.W. Frijlink, and W.L.J. Hinrichs A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation J. Control. Release 144 2010 127 133
5. R.T. Bartus, D. Emerich, P. Snodgrass-Belt, K. Fu, H. Salzberg-Brenhouse, D. Lafreniere, L. Novak, E.-S. Lo, T. Cooper, and A.S. Basile A pulmonary formulation of l-dopa enhances its effectiveness in a rat model of Parkinson's disease J. Pharmacol. Exp. Ther. 310 2004 828 835
6. A.G. Balducci, S. Cagnani, F. Sonvico, A. Rossi, P. Barata, G. Colombo, P. Colombo, and F. Buttini Pure insulin highly respirable powders for inhalation Eur. J. Pharm. Sci. 2013
7. O.S. Usmani, M.F. Biddiscombe, and P.J. Barnes Regional lung deposition and bronchodilator response as a function of {beta}2-agonist particle size Am. J. Respirat. Crit. Care Med. 172 2005 1497 1504
8. K. Darwiche, P. Zarogoulidis, N.K. Karamanos, K. Domvri, E. Chatzaki, T.C. Constantinidis, S. Kakolyris, and K. Zarogoulidis Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology Future Oncol. 9 2013 505 525
9. M.C. McElroy, C. Kirton, D. Gliddon, and R.K. Wolff Inhaled biopharmaceutical drug development: nonclinical considerations and case studies Inhal. Toxicol. 25 2013 219 232
10. J. Patton, J. Bukar, and M. Eldon Clinical pharmacokinetics and pharmacodynamics of inhaled insulin Clin. Pharmacokinet. 43 2004 781 801
11. P.J. Kuehl, T.L. Anderson, G. Candelaria, B. Gershman, K. Harlin, J.Y. Hesterman, T. Holmes, J. Hoppin, C. Lackas, J.P. Norenberg, H. Yu, and J.D. McDonald Regional particle size dependent deposition of inhaled aerosols in rats and mice Inhal. Toxicol. 24 2012 27 35
12. Recommendations for the conduct of acute inhalation limit tests: prepared by the technical committee of the inhalation specialty section, society of toxicology, Fundam. Appl. Toxicol. 18 (1992) 321-327.
13. O.G. Raabe, M.A. Al-Bayati, S.V. Teague, and A. Rasolt Regional deposition of inhaled monodisperse coarse and fine aerosol particles in small laboratory animals Ann. Occup. Hyg. 32 1988 53 63
14. J. Kaur, P. Muttil, R.K. Verma, K. Kumar, A.B. Yadav, R. Sharma, and A. Misra A hand-held apparatus for "nose-only" exposure of mice to inhalable microparticles as a dry powder inhalation targeting lung and airway macrophages Eur. J. Pharm. Sci. 34 2008 56 65
15. L. Garcia-Contreras, J. Fiegel, M.J. Telko, K. Elbert, A. Hawi, M. Thomas, J. VerBerkmoes, W.A. Germishuizen, P.B. Fourie, A.J. Hickey, and D. Edwards Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model Antimicrob. Agents Chemother. 51 2007 2830 2836
16. B. Sinha, and B. Mukherjee Development of an inhalation chamber and a dry powder inhaler device for administration of pulmonary medication in animal model Drug Dev. Ind. Pharm. 38 2012 171 179
17. S.-A. Cryan, N. Sivadas, and L. Garcia-Contreras In vivo animal models for drug delivery across the lung mucosal barrier Adv. Drug Deliver. Rev. 59 2007 1133 1151
18. C. Duret, N. Wauthoz, R. Merlos, J. Goole, C. Maris, I. Roland, T. Sebti, F. Vanderbist, and K. Amighi In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice Eur. J. Pharm. Biopharm. 81 2012 627 634
19. M. Morello, C.L. Krone, S. Dickerson, E. Howerth, W.A. Germishuizen, Y.-L. Wong, D. Edwards, B.R. Bloom, and M.K. Hondalus Dry-powder pulmonary insufflation in the mouse for application to vaccine or drug studies Tuberculosis 89 2009 371 377
20. S.A.L. Audouy, G. van der Schaaf, W.L.J. Hinrichs, H.W. Frijlink, J. Wilschut, and A. Huckriede Development of a dried influenza whole inactivated virus vaccine for pulmonary immunization Vaccine 29 2011 4345 4352
21. D.-J. van Drooge, W.L.J. Hinrichs, B.H.J. Dickhoff, M.N.A. Elli, M.R. Visser, G.S. Zijlstra, and H.W. Frijlink Spray freeze drying to produce a stable [Delta]9-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation Eur. J. Pharm. Sci. 26 2005 231 240
22. J. Sánchez Colorimetric assay of alditols in complex biological samples J. Agric. Food Chem. 46 1998 157 160
23. R. Dreywood Qualitative test for carbohydrate material Ind. Eng. Chem. (Anal. Ed.) 18 1946 499
24. Penn-Century Inc.; Device Comparison Guide, 2012, pp. 1-5.
25. G. Pilcer, F. Vanderbist, and K. Amighi Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties J. Pharm. Sci. 98 2009 1463 1475
26. T. Mizoe, T. Ozeki, and H. Okada Application of a four-fluid nozzle spray drier to prepare inhalable rifampicin-containing mannitol microparticles AAPS PharmSciTech. 9 2008 755 761
27. H. Adi, P.M. Young, H.-K. Chan, H. Agus, and D. Traini Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease Eur. J. Pharm. Sci. 40 2010 239 247
28. W.L.J. Hinrichs, M.G. Prinsen, and H.W. Frijlink Inulin glasses for the stabilization of therapeutic proteins Int. J. Pharm. 215 2001 163 174
29. G.S. Zijlstra, B.J. Ponsioen, S.A. Hummel, N. Sanders, W.L.J. Hinrichs, A.H. de Boer, and H.W. Frijlink Formulation and process development of (recombinant human) deoxyribonuclease I as a powder for inhalation Pharm. Dev. Technol. 14 2009 358 368
30. R. Sharma, D. Saxena, A.K. Dwivedi, and A. Misra Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis Pharm. Res. 18 2001 1405 1410
31. J. Sung, D. Padilla, L. Garcia-Contreras, J. VerBerkmoes, D. Durbin, C. Peloquin, K. Elbert, A. Hickey, and D. Edwards Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery Pharm. Res. 26 2009 1847 1855
32. L. Garcia-Contreras, J.C. Sung, P. Muttil, D. Padilla, M. Telko, J.L. VerBerkmoes, K.J. Elbert, A.J. Hickey, and D.A. Edwards Dry powder PA-824 aerosols for treatment of tuberculosis in guinea pigs Antimicrob. Agents Chemother. 54 2010 1436 1442
33. J.L. Larson, S.-K. Kang, B.I. Choi, M. Hedlund, L.M. Aschenbrenner, B. Cecil, G. Machado, M. Nieder, and F. Fang A safety evaluation of DAS181, a sialidase fusion protein, in rodents Toxicol. Sci. 122 2011 567 578
34. J. Fiegel, L. Garcia-Contreras, M. Thomas, J. VerBerkmoes, K. Elbert, A. Hickey, and D. Edwards Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin Pharm. Res. 25 2008 805 811
35. G.S. Zijlstra, C.A. Brandsma, M.F.H. Harpe, G.M. Van Dam, D.J. Slebos, H.A.M. Kerstjens, A.H. De Boer, and H.W. Frijlink Dry powder inhalation of hemin to induce heme oxygenase expression in the lung Eur. J. Pharm. Biopharm. 67 2007 667 675